Literature DB >> 28384908

Cardiac Effect of Interstitial Lung Disease Correlated with Spirometry and Six Minute Walk Test.

Mitali Bharat Agrawal1, Nilkanth Tukaram Awad2.   

Abstract

INTRODUCTION: The cardiac effect of different pulmonary functions, six minute walk distance, arterial blood gases and saturation in Interstitial Lung Disease (ILD) is not much known. So this study, a tertiary care hospital experience that entails to know the various factors in Pulmonary Hypertension (PH) mentioned above causing PH and their correlation with PH. AIM: To study the correlation of PH in patients with ILD with spirometry and six minute walk test (6MWT).
MATERIALS AND METHODS: All consecutive patients with confirmed diagnosis of ILD taken over a period of 1½year in tertiary care hospital. 6MWT and spirometry were performed as per the American Thoracic Guidelines. Percent predicted 6 minute walk distance was calculated using Enright et al., and Indian reference equation. PH was diagnosed using 2-D echo. The spirometry variables and 6MWT were then correlated with the mean pulmonary artery pressure.
RESULTS: There were 75 patients. About 66.66 % had PH on 2-D echo. The mean% predicted six minute walk distance as per the Indian reference equation, pre- and post- exercise PaO2 as well as desaturation had a significant correlation with PH. Spirometry variables Forced Expiratory Volume in First Second (FEV1) and Forced Vital Capacity (FVC) did not correlate with PH.
CONCLUSION: Thus, the 6MWT correlated significantly with PH while spirometry did not.

Entities:  

Keywords:  Forced Expiratory Volume in First Second; Forced Vital Capacity; PaO2; Pulmonary hypertension

Year:  2017        PMID: 28384908      PMCID: PMC5376798          DOI: 10.7860/JCDR/2017/21357.9292

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  15 in total

1.  Interpretative strategies for lung function tests.

Authors:  R Pellegrino; G Viegi; V Brusasco; R O Crapo; F Burgos; R Casaburi; A Coates; C P M van der Grinten; P Gustafsson; J Hankinson; R Jensen; D C Johnson; N MacIntyre; R McKay; M R Miller; D Navajas; O F Pedersen; J Wanger
Journal:  Eur Respir J       Date:  2005-11       Impact factor: 16.671

2.  Standardisation of spirometry.

Authors:  M R Miller; J Hankinson; V Brusasco; F Burgos; R Casaburi; A Coates; R Crapo; P Enright; C P M van der Grinten; P Gustafsson; R Jensen; D C Johnson; N MacIntyre; R McKay; D Navajas; O F Pedersen; R Pellegrino; G Viegi; J Wanger
Journal:  Eur Respir J       Date:  2005-08       Impact factor: 16.671

Review 3.  Diffuse lung disease: product of genetic susceptibility and environmental encounters.

Authors:  P A Lympany; R M du Bois
Journal:  Thorax       Date:  1997-01       Impact factor: 9.139

4.  The ILD India Registry: a novel tool for epidemiological surveillance of interstitial lung disease in India.

Authors:  Virendra Singh; Bharat Bhushan Sharma
Journal:  Indian J Chest Dis Allied Sci       Date:  2013 Oct-Dec

5.  Retrospective study of interstitial lung disease in a tertiary care centre in India.

Authors:  Tiyas Sen; Zarir F Udwadia
Journal:  Indian J Chest Dis Allied Sci       Date:  2010 Oct-Dec

6.  Brain natriuretic peptide and exercise capacity in lung fibrosis and pulmonary hypertension.

Authors:  Hanno H Leuchte; Claus Neurohr; Rainer Baumgartner; Michael Holzapfel; Wolfgang Giehrl; Michael Vogeser; Jürgen Behr
Journal:  Am J Respir Crit Care Med       Date:  2004-04-15       Impact factor: 21.405

7.  Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT).

Authors:  Nazzareno Galiè; Marius M Hoeper; Marc Humbert; Adam Torbicki; Jean-Luc Vachiery; Joan Albert Barbera; Maurice Beghetti; Paul Corris; Sean Gaine; J Simon Gibbs; Miguel Angel Gomez-Sanchez; Guillaume Jondeau; Walter Klepetko; Christian Opitz; Andrew Peacock; Lewis Rubin; Michael Zellweger; Gerald Simonneau
Journal:  Eur Heart J       Date:  2009-08-27       Impact factor: 29.983

8.  Severe exacerbations and BODE index: two independent risk factors for death in male COPD patients.

Authors:  Juan José Soler-Cataluña; Miguel Angel Martínez-García; Lourdes Sánchez Sánchez; Miguel Perpiñá Tordera; Pilar Román Sánchez
Journal:  Respir Med       Date:  2009-01-07       Impact factor: 3.415

9.  Reference equations for the six-minute walk in healthy adults.

Authors:  P L Enright; D L Sherrill
Journal:  Am J Respir Crit Care Med       Date:  1998-11       Impact factor: 21.405

10.  Reference equations for 6-min walk test in healthy Indian subjects (25-80 years).

Authors:  Ramanathan Palaniappan Ramanathan; Baskaran Chandrasekaran
Journal:  Lung India       Date:  2014-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.